1. Home
  2. IMRX vs TGEN Comparison

IMRX vs TGEN Comparison

Compare IMRX & TGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • TGEN
  • Stock Information
  • Founded
  • IMRX 2008
  • TGEN 2000
  • Country
  • IMRX United States
  • TGEN United States
  • Employees
  • IMRX N/A
  • TGEN N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • TGEN
  • Sector
  • IMRX Health Care
  • TGEN
  • Exchange
  • IMRX Nasdaq
  • TGEN NYSE
  • Market Cap
  • IMRX 145.7M
  • TGEN 171.8M
  • IPO Year
  • IMRX 2021
  • TGEN N/A
  • Fundamental
  • Price
  • IMRX $4.18
  • TGEN $6.58
  • Analyst Decision
  • IMRX Strong Buy
  • TGEN
  • Analyst Count
  • IMRX 4
  • TGEN 0
  • Target Price
  • IMRX $13.25
  • TGEN N/A
  • AVG Volume (30 Days)
  • IMRX 3.2M
  • TGEN 584.6K
  • Earning Date
  • IMRX 08-05-2025
  • TGEN 08-11-2025
  • Dividend Yield
  • IMRX N/A
  • TGEN N/A
  • EPS Growth
  • IMRX N/A
  • TGEN N/A
  • EPS
  • IMRX N/A
  • TGEN N/A
  • Revenue
  • IMRX N/A
  • TGEN $23,711,209.00
  • Revenue This Year
  • IMRX N/A
  • TGEN $155.81
  • Revenue Next Year
  • IMRX N/A
  • TGEN $19.42
  • P/E Ratio
  • IMRX N/A
  • TGEN N/A
  • Revenue Growth
  • IMRX N/A
  • TGEN N/A
  • 52 Week Low
  • IMRX $1.00
  • TGEN $0.67
  • 52 Week High
  • IMRX $4.60
  • TGEN $9.38
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 68.29
  • TGEN N/A
  • Support Level
  • IMRX $3.95
  • TGEN N/A
  • Resistance Level
  • IMRX $4.55
  • TGEN N/A
  • Average True Range (ATR)
  • IMRX 0.42
  • TGEN 0.00
  • MACD
  • IMRX 0.04
  • TGEN 0.00
  • Stochastic Oscillator
  • IMRX 75.72
  • TGEN 0.00

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About TGEN TECOGEN INC

Tecogen Inc, designs, manufactures, markets, and maintains high-efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services, and Energy Production. Products segment designs, manufactures, and sells industrial and commercial cogeneration systems. The services segment provides operations and maintenance services and turn-key installation for products under long-term service contracts. The Energy Production segment sells energy in the form of electricity, heat, hot water, and cooling to the customers under long-term energy sales agreements.

Share on Social Networks: